Direct letters to relatives at risk of hereditary cancer—a randomised trial on healthcare-assisted versus family-mediated risk disclosure
Hans Ehrencrona(Lund University), Anna Rosén(Unknown), Sigrid Wennstedt(Umeå University), Barbro Numan Hellquist(Umeå University), Anna Öfverholm(Swedish Institute), Carolina Hawranek(Umeå University), Lovisa Lovmar(Sahlgrenska University Hospital), S. Leif Svensson(Lund University)
Cited by 6
Related Papers
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer
|JAMA|2015|507
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in <i>RAD51C</i> and <i>RAD51D</i>
|JNCI Journal of the National Cancer Institute|2020|163
DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
|PLoS Genetics|2014|130
Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility
|Genetics in Medicine|2017|93
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers
|Human Molecular Genetics|2011|77